Diabetes mellitus-induced lower urinary tract symptoms and hepatic steatosis in an older male.
Nnennaya U OparaPublished in: Endocrinology, diabetes & metabolism case reports (2022)
Men with type 2 diabetes mellitus (DM-2) tend to have significantly lower serum PSA level, lower testosterone levels, and larger prostate volume compared to non-diabetic male patients. Patients with DM-2 have higher prevalence of hepatic steatosis, liver cirrhosis, and end-stage liver failure. The role of metformin in reducing hepatic steatosis as stated by several studies is yet to be validated as our patient has been on metformin for 22 years for the management of DM-2 with fatty liver disease.
Keyphrases
- lower urinary tract symptoms
- benign prostatic hyperplasia
- liver failure
- prostate cancer
- end stage renal disease
- glycemic control
- ejection fraction
- newly diagnosed
- type diabetes
- hepatitis b virus
- middle aged
- physical activity
- prognostic factors
- high glucose
- risk factors
- case report
- fatty acid
- oxidative stress
- drug induced
- adipose tissue
- replacement therapy
- patient reported
- smoking cessation